1. Home
  2. HDRN vs TLSA Comparison

HDRN vs TLSA Comparison

Compare HDRN & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hadron Energy Inc. Common Stock

HDRN

Hadron Energy Inc. Common Stock

N/A

Current Price

$1.77

Market Cap

148.0M

Sector

Utilities

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$0.91

Market Cap

145.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDRN
TLSA
Founded
N/A
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
148.0M
145.1M
IPO Year
2024
2017

Fundamental Metrics

Financial Performance
Metric
HDRN
TLSA
Price
$1.77
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
62.5K
598.6K
Earning Date
N/A
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$0.76
52 Week High
$2.67
$2.35

Technical Indicators

Market Signals
Indicator
HDRN
TLSA
Relative Strength Index (RSI) 51.43 47.29
Support Level $1.75 $0.90
Resistance Level $2.06 $1.20
Average True Range (ATR) 0.19 0.09
MACD -0.02 -0.01
Stochastic Oscillator 47.28 63.08

Price Performance

Historical Comparison
HDRN
TLSA

About HDRN Hadron Energy Inc. Common Stock

Hadron Energy Inc is a nuclear technology company focused on developing factory-fabricated, transportable 10 megawatt-electric (MWe) micro-modular reactors (MMRs) to meet the growing demand for clean, reliable, and affordable power. The company aims to deliver scalable, carbon-free energy solutions that can be rapidly deployed to power a variety of industries, including data centers, industrial facilities, remote communities, government installations and more. The market segments for its proprietary reactor, Hadron Halos, are Data Centers, Industrial Facilities and Heavy Manufacturing, Remote Communities and Critical Infrastructure, and Utilities and Distributed Energy.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: